Eosinophilic "empyema" associated with crack cocaine use

Thorax

Volumn 58, Issue 9, 2003, Pages 823-824

  Strong, D H ^a   Westcott, J Y ^b   Biller, J A ^a   Morrison, J L ^a   Effros, R M ^a   Maloney, J P ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PREDNISONE; VASCULOTROPIN;

ACID FAST BACTERIUM; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE ASSOCIATION; EFFUSION; EMPYEMA; EOSINOPHIL; FEVER; HUMAN; HYPOTHESIS; INFLAMMATION; LOEFFLER PNEUMONIA; LUNG EDEMA; LUNG LAVAGE; MALE; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; SMOKING; SWEAT; TRANSBRONCHIAL BIOPSY;

ADMINISTRATION, ORAL; ADULT; BRONCHOALVEOLAR LAVAGE FLUID; COCAINE-RELATED DISORDERS; CRACK COCAINE; EMPYEMA, PLEURAL; GLUCOCORTICOIDS; HUMANS; MALE; PREDNISONE; PULMONARY EOSINOPHILIA;

EID: 0042831240     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.9.823     Document Type: Article

References (17)

1. Forrester JM, Steele AW, Waldron JA, et al. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis 1990;142:462-7.
2. Heffner JE, Harley RA, Schabel SI. Pulmonary reactions from illicit substance abuse. Clin Chest Med 1990;11:151-62.
3. Horiuchi T, Weller PF. Expression of vascular endothelial growth factor by human eosinophils: upregulatian by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 1997;17:70-7.
4. Gan X, Zhang L, Berger O, et al. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin Immunol 1999;91:68-76.
5. Baldwin GC, Buckley DM, Roth MD, et al. Acute activation of circulating polymorphonuclear neutrophils following in vivo administration of cocaine. A potential etiology for pulmonary injury. Chest 1997;111:698-705.
6. Broide DH. Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 2001;108:S65-71.
7. Larangeira AP, Silva AR, Gomes RN, et al. Mechanisms of allergenand LPS-induced bone marrow eosinophil mobilization and eosinophil accumulation into the pleural cavity: a role for CD11b/CD18 complex. Inflamm Res 2001;50:309-16.
8. Perez SA, Silva PM, Martins MA, et al. Eosinophil granulocyte proliferation induced by an intermediate factor generated in the pleural cavity of rats injected with platelet- activating factor. Int Arch Allergy Immunol 1993;102:368-74.
9. Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 1999;85:178-87.
10. Cheng D, Rodriguez RM, Perkett EA, et al. Vascular endothelial growth factor in pleural fluid. Chest 1999;116:760-5.
11. Marie C, Losser MR, Fitting C, et al. Cytokines ond soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Am J Respir Crit Care Med 1997;156:515-22.
12. Greenburg M, Schiffman RL, Geha DG. Letter to the editor. N Engl J Med 1990;322:635.
13. Erzurum SC, Underwood GA, Hamilos DL, et al. Pleural effusion in Churg-Strauss syndrome. Chest 1989;95:1357-9.
14. Collins PD, Connolly DT, Williams TJ. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol 1993;109:195-9.
15. Klekamp JG, Jarzecka K, Hoover RL, et al. Vascular endothelial growth factor is expressed in ovine pulmonary vascular smooth muscle cells in vitro and regulated by hypoxia and dexamethasone. Pediatr Res 1997;42:744-9.
16. Joyce DA, Gimblett G, Steer JH. Targets of glucocorticoid action on TNF-alpha release by macrophages. Inflamm Res 2001;50:337-40.
17. Walsh GM. Human eosinophils: their accumulation, activation and fate. Br J Haematol 1997;97:701-9.